Tuesday, July 31, 2012
Wednesday, July 18, 2012
PRAGUE: Antonin Holy Has Died
PRAGUE — Antonin Holy, a renowned Czech scientist whose research significantly contributed to the development of antiviral drugs, has died, his long-time research institute said Tuesday.
Prague’s Institute of Organic Chemistry and Biochemistry of the Academy of Sciences where Mr. Holy has been working since 1960 says he died Monday after battling an unspecified long-term disease. He was 75.
He died the same day the U.S. Food and Drug Administration approved a drug Mr. Holy helped to create Truvada, which is made by the U.S. pharmaceutical company Gilead Sciences, is the first drug shown to reduce the risk of HIV infection. It is intended to be taken as a preventive measure for healthy people who are at high risk of acquiring HIV through sexual activity, such as those who have HIV-infected partners.
Mr. Holy, a research professor of nucleic acid chemistry, helped discover substances that are part of today’s drugs, such as Viread and Vistide, which are used for treatment of HIV-infected patients, and Hepsera, which is used to treat hepatitis B.
Mr. Holy had more than 60 patents to his name and was an author of about 600 scientific papers. Since 1976, he worked closely with professor Erik De Clercq from the Leuven University, Belgium.
Holy was born Sept 1, 1936, in Prague.He retired a year ago.
“Science is a real hard work,” he said. AP
Thursday, January 19, 2012
Some Good News: 96 percent of HIV transmission among Couples can be prevented by antireroviral drugs
HPTN 052 evaluated whether antiretroviral drugs can prevent
sexual transmission of HIV among couples in which one partner has HIV and the other does not. The research found that early treatment with antiretroviral therapy reduced HIV transmission in couples by at least 96 percent.
The study was funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
The complete list of top 10 scientific breakthroughs of the year was published online today.
The editors at Science, the flagship publication of the American Academy for the Advancement of Science, said in their announcement that "In combination with other promising clinical trials, the results have galvanized efforts to end the world's AIDS epidemic in a way that would been inconceivable even a year ago.
'The goal of an AIDS-free generation is ambitious, but it is possible,' U.S. Secretary of State Hillary Clinton told scientists last month."
sexual transmission of HIV among couples in which one partner has HIV and the other does not. The research found that early treatment with antiretroviral therapy reduced HIV transmission in couples by at least 96 percent.
The study was funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
The complete list of top 10 scientific breakthroughs of the year was published online today.
The editors at Science, the flagship publication of the American Academy for the Advancement of Science, said in their announcement that "In combination with other promising clinical trials, the results have galvanized efforts to end the world's AIDS epidemic in a way that would been inconceivable even a year ago.
'The goal of an AIDS-free generation is ambitious, but it is possible,' U.S. Secretary of State Hillary Clinton told scientists last month."
Monday, November 30, 2009
The first case of HIV/AIDS cure and no mention in the media. Why?
FOLEY, Ala. — A Foley physician said what appears to be the first case of HIV/AIDS cure in the world is getting little mention in the media.
Dr. Awadhesh K. Gupta, medical director at Foley Walk-In Med Care, said he first heard of the medical breakthrough in April when he attended the Annual Conference of the American College of Physicians in Internal Medicine in Philadelphia.
It’s a conference Gupta tries to attend every year.
“This is the most prestigious organization of physicians in Internal Medicine and is responsible for certifying post graduate training in Internal Medicine. It is also one of the oldest,” he said.
According to Gupta, who has been practicing medicine in the South Baldwin area since 1997, the cure was first reported in early 2008 by a group of physicians from Germany at the annual conference on “Retroviruses and Opportunistic Infections” in Boston. The New England Journal of Medicine, one of the most prestigious medical journals in the world, finally published the report in its Feb. 12, 2009, issue, Gupta said.
So why has the news of the first case of HIV/AIDS cure received so little attention where the public is concerned?
“I can’t be sure as to why so little publicity,” Gupta said recently.
Dr. Awadhesh K. Gupta, medical director at Foley Walk-In Med Care, said he first heard of the medical breakthrough in April when he attended the Annual Conference of the American College of Physicians in Internal Medicine in Philadelphia.
It’s a conference Gupta tries to attend every year.
“This is the most prestigious organization of physicians in Internal Medicine and is responsible for certifying post graduate training in Internal Medicine. It is also one of the oldest,” he said.
According to Gupta, who has been practicing medicine in the South Baldwin area since 1997, the cure was first reported in early 2008 by a group of physicians from Germany at the annual conference on “Retroviruses and Opportunistic Infections” in Boston. The New England Journal of Medicine, one of the most prestigious medical journals in the world, finally published the report in its Feb. 12, 2009, issue, Gupta said.
So why has the news of the first case of HIV/AIDS cure received so little attention where the public is concerned?
“I can’t be sure as to why so little publicity,” Gupta said recently.
Subscribe to:
Posts (Atom)